KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Illumina (ILMN) EBITDA (2016 - 2025)

Illumina (ILMN) has disclosed EBITDA for 17 consecutive years, with $201.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 15.52% year-over-year to $201.0 million, compared with a TTM value of $807.0 million through Dec 2025, up 196.88%, and an annual FY2025 reading of $807.0 million, up 196.88% over the prior year.
  • EBITDA was $201.0 million for Q4 2025 at Illumina, down from $228.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $741.0 million in Q3 2024 and bottomed at -$4.0 billion in Q1 2023.
  • Average EBITDA over 5 years is -$459.7 million, with a median of $34.5 million recorded in 2021.
  • The sharpest move saw EBITDA plummeted 1760.23% in 2024, then skyrocketed 247.75% in 2025.
  • Year by year, EBITDA stood at -$545.0 million in 2021, then plummeted by 571.01% to -$3.7 billion in 2022, then soared by 95.52% to -$164.0 million in 2023, then soared by 206.1% to $174.0 million in 2024, then rose by 15.52% to $201.0 million in 2025.
  • Business Quant data shows EBITDA for ILMN at $201.0 million in Q4 2025, $228.0 million in Q3 2025, and $214.0 million in Q2 2025.